Hendrik Fuchs is a professor at the Institute for Laboratory Medicine, Clinical Chemistry, and Pathobiochemistry at the Charité – Universitätsmedizin Berlin in Germany. Dr. Fuchs has spent more than 20 years researching the development of protein-based targeted anti-tumor therapeutics and is widely recognized as a pioneer in the use of saponins for endosomal escape. He is the coordinator of a large European project on targeted gene delivery and has published over 100 peer-reviewed articles. Before his professorship at the Charité – Universitätsmedizin Berlin, Dr. Fuchs was an Associate Professor and Group Leader at the Benjamin Franklin University Hospital, Berlin. He holds a PhD from Humboldt University Berlin.